Dr. Preet Paul Singh, MD

Dr. Singh practices at Springfield Clinic Urgent Care - Main in Springfield, Illinois.

Dr. Singh's NPI, 1881859833, was assigned on July 18, 2008. Dr. Singh holds Illinois license 036140585.

Dr. Singh's primary practice is Springfield Clinic Urgent Care - Main, at 1025 S 6th St, Springfield, IL 62703. The practice phone is (217) 528-7541.

Dr. Singh's primary practice is Springfield Clinic Urgent Care - Main in Springfield, Illinois. Dr. Singh is also affiliated with Springfield Memorial Hospital. The medical group on file is Springfield Clinic. Dmand AI also links Dr. Singh to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account. Dr. Singh's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Singh is licensed in Illinois.

CMS data shows 51,096 Medicare services from Dr. Singh across 33 procedure codes in 2024, for 325 Medicare patients. Medicare paid $792,255 for them. Every service was in an office.

CMS counts 325 Medicare patients who saw Dr. Singh in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 67, with 64% women.

In 2024, Dr. Singh wrote 1,628 Medicare Part D claims for 276 patients. 79% of them were for generic drugs. CMS names the drug for 1,374 of them, across 34 drugs with 11 or more claims each, at $3,008,648 in total drug cost. In 2023, CMS named 1,215 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Singh for performance year 2024, reported through an alternative payment model (APM). Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Singh, published from 2012 to 2017. 2013 was the busiest year, with 11. The most frequent topics are Carcinoma, Hepatocellular, Liver Neoplasms and Obesity. Dr. Singh has published most often in Am J Gastroenterol. Dr. Singh's most frequent co-authors are Siddharth Singh, MBBS, Mohammad Hassan Murad, MD and Vinay K. Gupta, MD.

Dmand AI links Dr. Singh to 4 clinical trials, 3 of them phase 1 studies. Conditions studied include Pancreatic Neoplasms, Pancreatic Diseases and Cholangiocarcinoma. Washington University School of Medicine sponsors the most, 4. Open Payments lists research payments to Dr. Singh that name 1 trial.

CMS Open Payments shows 122 general payments to Dr. Singh from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Eisai Inc. paid the most, $6,036. It also lists 4 research payments totaling $446,016 from 2024 to 2025, naming 1 clinical trial.